Exclusive: Ultimate biotech insider Dan Lynch takes his 30 years of experience to GV to fill a newly-created post
At every point over the past few years, Dan Lynch has filled a whole slate of board chair posts in the biotech world. He’s been the quiet board leader at Blueprint Medicines for the past 9 years — as the company went from being a pure-play R&D outfit to a drug marketer — and over the past decade helped coach 16 different companies as chairman or board member, including bluebird bio and Nimbus.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.